SAFETY DATA SHEET
Product:
Revision Date:835
6/01/2015

1. MATERIAL IDENTIFICATION
Product Name:

Ceramabond 835

Product Description:
Product Use:Tan, Odorless Paste
High Temperature Adhesive

Manufacturer:

Aremco Products, Inc.
707-B Executive Blvd.
Valley Cottage, NY 10989

Telephone:
Emergency Phone:845-268-0039
845-268-0039 or Infotrac (24/7) 800-535-5053

2. HAZARDS IDENTIFICATIONGHS Classification:
Eye Irritation
Skin Irritation
Carcinogenicity*
STOT RE, Respiratory*Category 2ACategory 2
Category 1ACategory 2* This product is a mixture and all powders are encapsulated. Carcinogenicity and respiratory referred to above only applies to dried liquid that may
powder and become airborne.
GHS Symbol:

GHS Signal Word:
Warning
GHS Hazard Determining Components:
Silicate Solution
Alumino-Silicate
Alumina-Silica Refractory Ceramic Fiber
Zirconium Silicate
GHS Hazard Statements for Health Hazards:
H303
Harmful if swallowed.
H315
Causes skin irritation.
H319
Causes serious eye irritation.
H350
May Cause Cancer by Inhalation
H373
STOT RE, Respiratory
GHS Precautionary Statements - Prevention:
P202
Do not handle until all safety precautions have been read and understoodP260
Do not breathe dust/fume/gas/mist/vapors/spray
P264
Wash hands thoroughly after handling.
P280
Wear protective gloves and eye protection.
P281
Use personal protective equipment as required
GHS Precautionary Statements – Response:
P302+P352
IF ON SKIN: Wash with plenty of soap and water
P332+P313
If skin irritation occurs, get medical attention
P362
Take off contaminated clothing and wash before reuse
P305+P351+P338
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses
if present and easy to do and continue rinsing
P313+P337
If eye irritation persists, get medical attention
P312
IF SWALLOWED: Call a poison center or doctor if you feel unwellP308+P313
IF exposed or concerned: Get medical advice/attention
1

GHS Precautionary Statements - Storage/Disposal:
P501
Dispose in accordance with local, regional, national or international regulations.

3. COMPOSITION
Chemical

CAS No.

EC No.

Concentration

Silicate Solution1312-76-1

215-687-4

10.0-20.0%

Zirconium Silicate

14940-68-2

239-019-6

40.0-60.0%

Alumino-Silica Fiber

142844-00-6

604-314-4

5.0-15.0%

Alumino-Silicate
Water

1332-58-7
7732-18-5

310-194-1
N/A

1.0-5.0%
25.0-35.0%

GHS Product Identifier
H302 Acute Toxicity, Oral, Cat 4
H315 Skin Corrosion/Irritation, Cat 2
H319 Eye Damage/Eye Irritation, Cat 2A
H335 STOT, SE; Respiratory Tract Irritation, Cat 3
H315 Skin Irritation, Cat 2
H320 Eye Irritation, Cat 2B
H350 May Cause Cancer by Inhalation, Cat 1A
H373 STOT RE, Respiratory, Cat 2
H315 Skin Corrosion/Irritation, Cat 2
H319 Serious Eye Damage/Eye Irritation, Cat 2A
H350 May Cause Cancer by Inhalation, Cat 1B
H335 STOT, RE; Respiratory Tract Irritation, Cat 3
None

Notes
1) This product is a mixture and all powders are encapsulated.
2) Zirconium Silicate contains traces of crystalline silica and 0.0028-0.028% Uranium and 0.0085-0.015% Thorium, which exists in complex
mineralogical phase within zircon.

4. FIRST AID MEASURES
After eye contact:
After skin contact:
After inhalation:
After ingestion:
Medical Conditions Possibly
Aggravated by Exposure:

Hold eyelids open and flush with a steady, gentle stream of water for at least 15 minutes. Seek immediate
medical attention, preferably with an ophthalmologist.
Immediately wipe excess material off skin with a dry cloth then wash with soap and water for at least 5 minutes.
In case of inhalation due to spray mist, machining dust or dried particulate, remove source of exposure andassure that victim is breathing. If not breathing, administer cardio-pulmonary resuscitation (CPR).
If swallowed, do not induce vomiting. If victim is conscious and alert, give 1-2 glasses of water to drink. Do notgive anything by mouth to an unconscious person. Seek medical attention immediately.
Inhalation of product may aggravate existing chromic respiratory problems such as asthma, emphysema or
bronchitis. Skin contact may aggravate existing skin disease.

5. FIRE FIGHTING MEASURES
Flash Point:
Flammable Limits:
Extinguishing Media:
Special Fire Fighting Procedures:

Not applicableThis material is non-combustible.
This material is compatible with all extinguishing media.
Firefighters should wear NIOSH/MSHA approved positive pressure breathing apparatus with full face-piece andfull chemical resistant protective clothing. Dike area to prevent runoff and contamination of water sources.
Dispose of fire control water later.
Unusual Fire and Explosion Hazards: This material is non-combustible.

6. ACCIDENTAL RELEASE MEASURES
Personal Protection:
Spill Cleanup:

Wear chemical goggles, body-covering protective clothing, chemical resistant gloves, and rubber boots. Use
NIOSH approved respirator where mist occurs.
Mop up and neutralize liquid, then discharge to sewer in accordance with federal, state and local regulations or
permits. Flush area with water to complete cleanup. Exercise caution during neutralization as heat may begenerated.

7. HANDLING AND STORAGE
Handling:
Storage:

Avoid contact with eyes, skin and clothing. Avoid breathing spray mist. Keep container closed. Promptly clean
residue from closures with cloth dampened with water. Promptly clean up spills.
Store in an area that is cool, dry, well ventilated, away from combustible material, and away from ignition
sources. Keep containers closed. Store in clean plastic or stainless steel containers.
2

8. EXPOSURE CONTROLS / PERSONAL PROTECTION
ChemicalAlumino-Silica Fiber
Alumino-Silicate
Zirconium Silicate
Silicate Solution
Water
Engineering Controls:
Respiratory Protection:

Skin Protection:
Eye Protection:

CAS No.
142844-00-6
1332-58-7
14940-68-2
1344-09-8
7732-18-5

EC No.
604-314-4
310-194-1
239-019-6
215-687-4
N/A

3

TLV (mg/m )Not established
No available information
5
No available information
No available information

3

PEL (mg/m )Not established55
No available information
No available information

Use with adequate ventilation. Keep containers closed. Safety shower and eyewash fountain should be within
direct access.
This product is not considered respirable in either the liquid or cured forms. However, if the cured product ispolished, ground or chipped during processing, handling or use, powders may be released as airborne
respirable particles. In these instances, appropriate personal protection equipment and local ventilation controls
must be employed. If exposure limits are exceeded and local ventilation is unavailable, a supplied-air respirator
or a self-contained NIOSH-approved dust and mist respirator is required.
Wear body-covering protective clothing and gloves.
Wear chemical goggles.

9. PHYSICAL AND CHEMICAL PROPERTIES
Physical and chemical here represent typical properties of this product. Contact Technical Sales for exact specifications.
Appearance:
Color:
Odor:
pH:
Specific Gravity, g/cc
Water Solubility:
Melting Point:
Boiling Point:
Vapor Pressure:
Vapor Density (air=1):
VOC Content:
Viscosity:
Decomposition Temperature:
Auto-ignition TemperaturePartition Coefficient:Flash Point:
Flammability:
Evaporation Rate:

Paste
Tan
Odorless11.0-11.5
2.30
SolubleNot applicableo
100 C
Not applicable
No data
0.00 lbs/gal
20,000-40,000 cP
Not applicableNot applicable
No data
Not applicableNot applicableNot applicable

10. STABILITY AND REACTIVITY
Chemical Stability:
This material is stable under all conditions of use and storage.
Conditions to Avoid:
Prolonged contact with aluminum, brass, copper, lead, and zinc may produce flammable hydrogen gas.
Materials to Avoid:
Gels and heats when mixed with acid. May react with ammonium salts resulting in evolution of ammonia gas.
Hazardous Decomposition Products: None.
Hazardous Polymerization:Will not occur.

11. TOXICOLOGICAL INFORMATION
Acute Toxicity:

Component: CAS No. 1344-09-8, Silicate Solution
LD50 Oral, 1153 mg/kg (Rat)
LD50, Inhalation, No Data
LD50, Dermal, 4640 mg/kg (Rabbit)

Skin Corrosion/Irritation:
Serious Eye Damage/Irritation:
Sensitization:
Mutagenicity:
Reproductive Toxicity:

Irritating to skin
Irritating to eyes
Not sensitizing
No data
No data3

Acute Toxicity:

Component: CAS No. 14940-68-2, Zirconium Silicate
No Data

Chronic Toxicity:

Zircon contains naturally occurring radioactive materials (NORM) in the uranium and thorium series, inequilibrium, at typical specific activities of 0.3 to 0.7 Bq/g thorium (85-165 ppm) and 0.3 to 3.5 Bq/g uranium (28281 ppm). Zircon is exempt from Nuclear Regulatory Commission (NRC) regulations for source material per 10
CFR 40, since it falls under the definition of “unimportant quantity source material” containing less than 0.05%
uranium or thorium. The main radiological hazard from the product is internal exposure from small amounts ofalpha particles given off by inhaled dust. Industrial hygiene practices aimed at control of airborne dust canlessen the potential for exposure. Overexposure by inhalation to inhaled dusts containing radioactive uraniumor thorium may cause lung cancer. Low level gamma radiation in proximity to bulk stockpiles of zircon may
present a lesser, external exposure that can be managed by limiting close proximity for long time periods tolarge volumes of material. IARC and NTP do not list Zircon as a carcinogen.
This product contains < 0.5% crystalline silica; once inhaled, cristobalite can remain in the lungs causing
scarring, stiffening and difficulty breathing. The most common type of silicosis develops following repeatedinhalation over time. Repeated inhalation of crystalline silica can also increase the risks of developing
respiratory cancer. Avoid dust creation. Do not inhale dusts from this product. Do not use compressed air or
dry sweeping to remove dusts from the work area. Use wet clean-up methods to remove dusts. IARC and NTP
classify respirable crystalline silica as a confirmed or known human carcinogen. Although OSHA has notpromulgated a specific standard for crystalline silica, materials that contain >= 0.1% crystalline silica should betreated as a confirmed carcinogen for hazard communication purposes.
Acute silicosis has been reported for exposure to extremely high crystalline silica concentrations particularly
when the particle size of the dust is very small. Acute silicosis is rapidly progressive with diffuse pulmonary
involvement and does not form classical silicotic nodules. The disease is often complicated by tuberculosis andcan develop only months after the initial exposure with the possibility of death within 1 or 2 years. This productcontains < 0.50% crystalline silica. Acute silicosis may not occur at the concentrations present.
Silica particles <10 microns are considered respirable; however, particles retained in the lungs are generally
much smaller. Silica particles retained in the human lung have median diameters of 0.5-0.7 microns.
Classic silicosis is characterized by the formation of scattered silica containing nodules of scar tissue in thelungs ranging in size from microscopic to greater than 1 cm. Simple silicosis (nodules < 1 cm) is generally
asymptomatic but may progress to debilitating complicated silicosis (nodules > 1 cm) with or without continued
exposure. Historically, workers who developed silicosis had greatly increased risks of developing anaccompanying tuberculosis infection (silicotuberculosis).
IARC has found inadequate evidence to link exposure to amorphous silica to cancer in animals. Limited data isavailable concerning the health effects of fused silica in animals or humans; however, animal studies indicate afibrogenic potential less than that of quartz. IARC has found inadequate evidence to link exposure toamorphous silica to cancer in animals.

.

Overexposure by inhalation to inhaled dusts containing radioactive uranium or thorium may cause lung cancer.
Low level gamma radiation in proximity to bulk stockpiles of zircon may present a lesser, external exposure thatcan be managed by limiting close proximity for long time periods to large volumes of material. IARC and NTP
do not list Zircon as a carcinogen.

Acute Toxicity:

Component: CAS No. 142844-00-6, Alumina-Silica Refractory Ceramic Fiber (RCF)

Toxicokinetics, Metabolism& Distribution:

Basic Toxicokinetics
Exposure is predominantly by inhalation or ingestion. Man made vitreous fibers of a similar size to RCF havenot been shown to migrate from the lung and/or gut and do not become located in other parts of the body.
When compared to many naturally occurring minerals, RCF has a low ability to persist and accumulate in the
body (half-life of long fibers (> 20- microns) in 3 week rat inhalation test is approximately 60 days.)
Human Toxicological Data
In order to determine possible human health effects following RCF exposure, the University of Cincinnati has
been conducting medical surveillance studies on RCF workers in the U.S. The Institute of Occupational
Medicine (IOM) has conducted medical surveillance studies on RCF workers in European manufacturing
facilities.
Pulmonary morbidity studies among production workers in Europe and USA have demonstrated an absence ofinterstitial fibrosis and no decrements in lung function associated with current exposures, but have indicated a
reduction of lung capacity among smokers.
A statistically significant correlation between pleural plaques and cumulative RCF exposure was evidenced in
the USA longitudinal study.
The USA mortality study did not show evidence of increased lung tumor development either in the lungparenchyma or in the pleura.
4

Information on Toxicological
Effects:

Acute Toxicity: Short Term Inhalation
No data available: Short term tests have been undertaken to determine fiber (bio) solubility rather than toxicity;repeat dose inhalation tests have been undertaken to determine chronic toxicity and carcinogenicity.
Acute Toxicity: OralNo data available: Repeated dose studies have been carried out using gavage. No effect was found.
Skin Corrosion/Irritation:
Not possible to obtain acute toxicity information due to the nature of the substance
Serious Eye Damage/Irritation:
Not possible to obtain acute toxicity information due to the nature of the substanceRespiratory or Skin Sensitization:
No evidence from human epidemiological studies of any respiratory or skin sensitization potential
Germ Cell Mutagenicity:
Method:In vitro micronucleus test
Species:
Hamster (CHO)
Dose:
1-35 mg/ml
Routes of Admin: In suspension
Results:
Negative
Carcinogenicity:
Method:Species:
Dose:
Routes of Admin:
Results:

Carcinogenicity:
Method:Species:
Dose:
Routes of Admin:
Results:

Carcinogenicity:
Method:Species:
Dose:
Routes of Admin:
Results:

Inhalation. Multi-dose.
Rat
33, 9 and 16 mg/m
Nose only inhalation
3
3
Fibrosis just reached significant levels at 16 and 9 mg/m but not at 3 mg/m .
None of the parenchymal tumor incidences were higher than the historical control values forthis strain of animal.

Inhalation. Single dose.
Rat
3
30 mg/mNose only inhalation
This study was designed to test the chronic toxicity and Carcinogenicity of RCF at extreme
exposures. Tumor incidence (incl. Mesothelioma) was raised at this dose level. The
presence of overload conditions (only detected after the experiment was completed),
whereby the delivered dose exceeded the clearance capability of the lung, makes
meaningful conclusions in terms of hazard and risk assessment difficult.
Inhalation. Single dose.
Hamster
330 mg/mNose only inhalation
This low quality study in hamsters produced mesothelial lesions of uncertain significance.
Subsequent studies in hamsters with glass fibers indicated that the lung burdens of RCF in
this experiment were between 5 and 10 times more than that need to produce overload,
and the results are therefore difficult to interpret.
There are reports of injection studies with some similar materials. While someintraperitoneal injection studies reported the development of tumors in rats, the relationshipof these results to classification remains controversial.

Reproductive Toxicity:
Method:Gavage.
Species:
Rat
Dose:
250 mg/kg/day
Routes of Admin: Oral
Results:
No effects were seen in an OECD 421 screening study. There are no reports of any
reproductive toxic effects of mineral fibers. Exposure to these fibers is via inhalation andeffects seen are in the lung. Clearance of fibers is via the gut and the feces, so exposure of
the reproductive organs is extremely unlikely.
STOT SE:
STOT RE:Aspiration Haz:

Not Applicable
Not Applicable
Not Applicable5Irritant:

Negative results have been obtained in animal studies (EU method B 4) for skin irritation.
Inhalation exposures using the nose only route produce simultaneous heavy exposures tothe eyes, but no reports of excess eye irritation exist. Animals exposed by inhalation
similarly show no evidence of respiratory tract irritation. Human data confirm that only
mechanical irritation, resulting in itching, occurs in humans. Screening at manufacturer’s
plants has failed to sow any human cases of skin conditions related to fiber exposure.

12. ECOLOGICAL INFORMATION
Ecotoxity:
Biodegradation:
Persistence:
Bioconcentration:
Physical/Chemical:

This material is believed to be practically non-toxic to aquatic life.
This material is inorganic and not subject to biodegradation.
this material is believed to persist in the environment.
This material is not expected to bioconcentrate in organisms.
Sinks and mixes with water. Only water will evaporate from this material.

13. DISPOSAL CONSIDERATIONS
Disposal Method:

Dispose in accordance with federal, state and local regulations and permits.

14. TRANSPORTATION INFORMATIONDOT UN Status:

The material is not a regulated hazardous material for transportation.

15. REGULATORY INFORMATION
U.S. Federal Regulations
CERCLA:No CERCLA reportable quantity has been established for this material.

TSCA:

All ingredients of this material are listed on the TSCA inventory.

SARA Title III
Sections 302, 304, 313:

This product does not contain any substances reportable under these sections.

Sections 311, 312:
Hazard Classes
Fire Hazard
Reactivity Hazard
Pressure Hazard
Immediate Hazard
Delayed Hazard

Yes/No
No
No
No
Yes
No

International Inventory
Canada (DSL)
Europe (EINECS/ELINCS)
Australia (AICS)
Japan (MITI)South Korea (KECL)

Status
Yes
Yes
Yes
Yes
Yes

6

16. OTHER INFORMATIONNFPA Ratings (scale 0 – 4)

Health, 1
Flammability, 0
Reactivity, 0
Personal Protection, C

HMIS Ratings (scale 0 – 4)

Health, 1
Flammability, 0
Reactivity, 0
Personal Protection, C

Key Legend Information
ACGIH
ARD
CAS
CERCLA
DSL
EC
HMIS
IARC
ND
NE
NFPA
NIOSH
NTP
OSHA
PEL
RE
SARA
SARA Title III
SARA Section 302
SARA Section 304
SARA Section 311
SARA Section 312
SARA Section 313
SE
STEL
STOT
TLV
TWA

American Conference of Governmental Industrial Hygienists
International Agency for Research on Cancer
Chemical Abstract Service
Comprehensive Environmental Response, Compensation & Liability Act
Domestic Substance List
European Commission
Hazardous Materials Identification System
International Agency for Research on Cancer
Not Determined
Not Established
National Fire Protection Association
National Institute for Occupational Safety & HealthNational Toxicology Program
Occupational Safety and Health Administration
Permissible Exposure Limit
Repeat Exposure
Superfund Amendments & Reauthorization Act
Emergency Planning & Community Right to Know Act
Extremely Hazardous Substances
Emergency Release
MSDS/List of Chemicals & Hazardous Inventory
Emergency & Hazardous Inventory
Toxic Chemicals & Release Reporting
Single Exposure
Short Term Exposure Limit
Specific Target Organ Toxicity
Threshold Limit Value
Time Weighted Average

Disclaimer:
The information contained herein is based on data taken from sources believed to be both current and reliable at the time of
publication. Aremco Products, Inc. makes no warranty, expressed or implied, as to the accuracy of this MSDS and assumes no liability arising from its
use by others. Compliance with all applicable Federal, State and Local laws and regulations remains the responsibility of the user.

7